The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
β-Cell Function and the Development of Diabetes-Related Complications in the Diabetes Control and Complications Trial
Open accessAbstract
In patients with type 1 diabetes, measurement of connecting peptide (C-peptide), cosecreted with insulin from the islets of Langerhans, permits estimation of remaining β-cell secretion of insulin. In this retrospective analysis to distinguish the incremental benefits of residual β-cell activity in type 1 diabetes, stimulated (90 min following ingestion of a mixed meal) C-peptide levels at entry in the Diabetes Control and Complications Trial (DCCT) were related to measures of diabetic retinopathy and nephropathy and to incidents of severe hypoglycemia. Based on the analytical sensitivity of the assay (0.03 nmol/l) and study entry criteria, the DCCT subjects were divided into four groups of stimulated C-peptide responses: ≤0.03, 0.04–0.20, 0.21–0.50 nmol/l at entry, and 0.21–0.50 nmol/l at entry and at least 1 year later (sustained C-peptide secretion). Uniformly in the intensive and partially in the conventional DCCT treatment groups, any C-peptide secretion, but especially at higher and sustained levels of stimulated C-peptide, was associated with reduced incidences of retinopathy (both a single three-step change and a repeated three-step change on the Early Treatment of Diabetic Retinopathy Study [ETDRS] scale at the next 6 month visit) and nephropathy (both albuminuria >40 mg/24 h once and repeated at the next annual visit). There were also differences in severe hypoglycemia across C-peptide levels in both treatment groups. In the intensively treated cohort there were essentially identical prevalences of severe hypoglycemia (∼65% of participants) in the first three groups; however, those subjects with mixed-meal stimulated C-peptide level >0.20 nmol/l for at least baseline and the first annual visit in the DCCT experienced a reduced prevalence of ∼30%. Therefore, even modest levels of β-cell activity at entry in the DCCT were associated with reduced incidences of retinopathy and nephropathy. Also, continuing C-peptide (insulin) secretion is important in avoiding hypoglycemia (the major complication of intensive diabetic therapy).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although this endogenous secretion is typically low, maintenance is important since it is associated with less retinopathy and less severe hypoglycaemia at later stages of the disease.86”
From Type 1 diabetes (2014) · cites this paper as [86]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“natural history studies, intervention trials, and transplantation studies consistently show that higher Cpeptide responses to a mixed meal are associated with improved glycaemic control, fewer hypoglycaemic episodes, and reduced longterm complications.[55][56][57]”
From The future of type 1 diabetes therapy (2025) · cites this paper as [57]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This finding is noteworthy because in the Diabetes Control and Complications Trial68,69 persistent C-peptide secretion was associated with reduced development of retinopathy, nephropathy, and hypoglycaemia.”
From Type 1 diabetes (2018) · cites this paper as [69]
In the citing paper
“In addition, we analysed two other thresholds: UCPCR≥0.03 nmol/mmol and ≥0.2nmol/mmol, which are equivalent to serum C peptide of 30 pmol/L (a common historical limit of detection(3; 11; 12)) and 200 pmol/L (a clinically defined level associated with reduced microvascular complications and hypoglycaemia(13)).”
From Most people with long-duration type 1 diabetes in a large population-based study are insulin microsecretors (2015) · cites this paper as [11]
In the citing paper
“The strongest evidence to date, however, finds that while higher and sustained levels of C-peptide are most beneficial, even modest levels of β-cell function in some with long-term disease are associated with lower rates of hypoglycemia and lower incidence of retinopathy and nephropathy (9,11).”
From Persistence of prolonged C-peptide production in type 1 diabetes as measured with an ultrasensitive C-peptide assay (2012) · cites this paper as [11]
In the citing paper
“The strongest evidence to date, however, finds that while higher and sustained levels of C-peptide are most beneficial, even modest levels of β-cell function in some with long-term disease are associated with lower rates of hypoglycemia and lower incidence of retinopathy and nephropathy (9,11).”
From Persistence of prolonged C-peptide production in type 1 diabetes as measured with an ultrasensitive C-peptide assay (2012) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies
Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,602
The design and analysis of cohort studies
Breslow, N. E., & Day, N. E. (1987) · International Agency for Research on Cancer eBooks · Cited by 1,312
The Diabetes Control and Complications (DCCT) Research Group (1995) · Kidney International · doi:10.1038/ki.1995.236 · Cited by 694
Gerich, J. E., Langlois, M., Noacco, C., Karam, J. H., & Forsham, P. H. (1973) · Science · doi:10.1126/science.182.4108.171 · Cited by 688
(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-7-199804010-00001 · Cited by 546
The DCCT Research Group (1986) · Diabetes · doi:10.2337/diabetes.35.5.530 · Cited by 466
(1995) · Archives of Ophthalmology · doi:10.1001/archopht.1995.01100010038019 · Cited by 325
Hypoglycemia: The Limiting Factor in the Management of IDDM
Cryer, P. E. (1994) · Diabetes · doi:10.2337/diab.43.11.1378 · Cited by 307
THE DCCT RESEARCH GROUP (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-1-30 · Cited by 215
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 697
Achenbach, P., Berner, R., Bonifacio, E. E., Brämswig, S., Braig, S., Dunstheimer, D., Ermer, U., Ewald, D., Gemulla, G., Hauer, J., et al. (2024) · Das Gesundheitswesen · doi:10.1055/a-2320-2859 · Cited by 8
Fureman, A., Bladh, M. K., Carlsson, A., Forsander, G., Lilja, M., Ludvigsson, J., Samuelsson, U., Särnblad, S., & Lind, T. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0112 · Cited by 6
Early glycaemic control is predictive of long‐term control: a retrospective observational study
Jackson, C., Wernham, E., Elder, C., & Wright, N. P. (2013) · Practical Diabetes · doi:10.1002/pdi.1734 · Cited by 6
Gabbay, M. A. L., Crispim, F., & Dib, S. A. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01014-z · Cited by 6
Wang, Y., Wang, X.-H., & Li, R. (2015) · PubMed · Cited by 6
Interdisciplinary Care Model: Diabetes and Oral Health
Shimpi, N. A., Ashton, J. L., Sorenson, C. A., Danial, L. O., O’Brien, J., Melms, W. F., & Acharya, A. (2018) · Health informatics · doi:10.1007/978-3-319-98298-4_4 · Cited by 6
Short Update on C-Peptide and its Clinical Value
Novac, C. N., Radulian, G., Orzan, A., & Bălgrădean, M. (2019) · MAEDICA – a Journal of Clinical Medicine · doi:10.26574/maedica.2019.14.1.53 · Cited by 6
Islet transplantation: an evidence-based analysis.
(2003) · Europe PMC (PubMed Central) · Cited by 6
Type 1 Diabetes in Youth and Technology-Based Advances in Management
Ferber, C., Mao, C. S., & Yee, J. K. (2020) · Advances in Pediatrics · doi:10.1016/j.yapd.2020.04.002 · Cited by 8
Moore, M. C., Warner, S. O., Dai, Y., SHEANON, N. M., Smith, M. S., Farmer, B., Cason, R. L., Cherrington, A. D., & Winnick, J. J. (2021) · JCI Insight · doi:10.1172/jci.insight.148997 · Cited by 7
Miao, H., Zhang, J., Gu, B., Gao, A., Hong, J., Zhang, Y., & Gu, W. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12912 · Cited by 6
Residual endogenous insulin secretion in Japanese children with type 1A diabetes
Sugihara, S., Kikuchi, T., Urakami, T., Yokota, I., Kikuchi, N., Kawamura, T., Amemiya, S., & on behalf of the Japanese Study Group of Insulin Therapy for Childhood and Adolescent Diabetes (JSGIT) (2021) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.30.27 · Cited by 6
Immune Intervention in Children with Type 1 Diabetes
for The Linköping Diabetes Immune Intervention study group, & Ludvigsson, J. (2010) · Current Diabetes Reports · doi:10.1007/s11892-010-0138-y · Cited by 6
Un autre regard sur les implications de l’étude DCCT
Krzentowski, G., Zhang, L., Albert, A., & Lefèbvre, P. J. (2004) · Annales d Endocrinologie · doi:10.1016/s0003-4266(04)95947-1 · Cited by 6
Köger, M., Winkler, C., Hummel, S., Weiß, A., Koutangni, T., Yates, M., Bonnemaire, M., Guenther, O., ZACCAI, J. H., & Ziegler, A. (2025) · Diabetes Care · doi:10.2337/dc25-1021 · Cited by 5
CVOT Summit Report 2025: advances along the cardiovascular–kidney–metabolic disease continuum
Schnell, O., Agarwal, A., Azizi, M., Ballwieser, D. A., Barnard-Kelly, K. D., Battelino, T., Ballwieser, D. A., Blüher, M., Bugianesi, E., Cebrián, A., et al. (2026) · Cardiovascular Diabetology · doi:10.1186/s12933-026-03140-0 · Cited by 5
Preservation of Residual Beta Cell Function with Vitamin D Supplementation in Type 1 Diabetes
Dayal, D., & Sachdeva, N. K. (2015) · Immunoendocrinology · doi:10.14800/ie.1093 · Cited by 5
Gao, H., Zhao, Q., Tang, S., Li, K., Qin, F., Song, Z., Pan, Y., Jin, L., & Zhang, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-83201-4 · Cited by 5
Residual β-Cell Function in Type 1 Diabetes Followed for 2 Years after 3C Study
Lin, K., Yang, X., Wu, Y., Chen, S., & Zeng, Q. (2021) · Journal of Diabetes Research · doi:10.1155/2021/9946874 · Cited by 5
Supporting patients with type 1 diabetes
Phillips, A. (2016) · British Journal of Nursing · doi:10.12968/bjon.2016.25.6.330 · Cited by 5
Tootee, A., Nasli‐Esfahani, E., Ghodsi, M., Razi, F., Amini, M., Larijani, B. A., & Heshmat, R. (2015) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 5
Oulghazi, S., Wegner, S. K., Spohn, G., Müller, N., Harenkamp, S., Stenzinger, A., Papayannopoulou, T., & Bonig, H. B. (2020) · Cells · doi:10.3390/cells9122597 · Cited by 5
N-3 PUFA and Pregnancy Preserve C-Peptide in Women with Type 1 Diabetes Mellitus
Đelmiš, J., Ivanišević, M., & Horvatiček, M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122082 · Cited by 5
Liu, W. Y., Ma, Y., Cai, X., Zhu, Y. M., Zhang, M., Li, J., Chen, J., Shi, D., & Ji, L. (2022) · Endocrine Connections · doi:10.1530/ec-22-0244 · Cited by 6
Islet transplantation for type 1 diabetes—where should we go?
Witkowski, P., & Herold, K. C. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0369 · Cited by 5
C-Peptide and Vascular Complications in Type 2 Diabetic Subjects
Son, S. M. (2012) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2012.36.5.345 · Cited by 5
NEW THERAPIES AIMED AT THE PRESERVATION OR RESTORATION OF BETA CELL FUNCTION IN TYPE 1 DIABETES
Keymeulen, B. (2006) · Acta Clinica Belgica · doi:10.1179/acb.2006.047 · Cited by 5
Immunotherapy for Type 1 Diabetes: Getting beyond a Negative First Impression
Pozzilli, P., & Strollo, R. (2012) · Immunotherapy · doi:10.2217/imt.12.54 · Cited by 5
Zhu, T., Chen, Q., Chen, H., You, L., Liu, D., Zhang, X., Li, F., Wu, H., Tang, J., Lin, D., et al. (2024) · Journal of Diabetes · doi:10.1111/1753-0407.13529 · Cited by 4
Nwosu, B. U. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1462249 · Cited by 4
Katte, J.-C. N., Morfaw-Kibula, F., Agoons, B. B., Zemsi, S., Guewo‐Fokeng, M., & Sobngwi, E. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.866107 · Cited by 4
Trabucchi, A., Bombicino, S. S., Sabljic, A. V., Marfía, J. I., Targovnik, A. M., Iacono, R. F., Miranda, M. V., & Valdez, S. N. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1219857 · Cited by 4
Diabetes — adult stem cells as an future alternative therapy?
Ulicna, M., Danišovič, Ľ., Danihel, L., & Vojtaššák, J. (2009) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03657270 · Cited by 4
Ni, X., Xu, Z., Wang, J., Zheng, S., & Cai, Y. (2020) · Transplant Immunology · doi:10.1016/j.trim.2020.101322 · Cited by 4
Greenbaum, C. J. (2012) · Diabetes Care · doi:10.2337/dc11-2441 · Cited by 4
Glutamic acid decarboxylase immunotherapy for type 1 diabetes
Ludvigsson, J. (2022) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000748 · Cited by 4
Seelig, E., Trinh, B., Hanssen, H., Schmidt‐Trucksäss, A., Ellingsgaard, H., Christ‐Crain, M., & Donath, M. Y. (2019) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.75 · Cited by 4
Metabolic and endocrine evaluation of islet transplant function
Rickels, M. R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814833-4.00045-9 · Cited by 4
Ghoreishi, A. S., Mahmoodi, M., & Khoshdel, A. (2022) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_905_21 · Cited by 4
Continuous C-peptide loss in patients with type 1 diabetes and multiethnic background
Dantas, J. R., de Almeida, M. H., Barone, B., Serfaty, F. M., Raggio, L. R., Kupfer, R., Zajdenverg, L., de Oliveira, J. E. P., & Rodacki, M. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.12.019 · Cited by 4
Role of C-Peptide in the Regulation of Microvascular Blood Flow
Forst, T. M., Weber, M. M., Kunt, T., & Pfützner, A. (2011) · Humana Press eBooks · doi:10.1007/978-1-61779-391-2_5 · Cited by 4
Diabetes Technology and Treatment in the Pediatric Age Group
Shalitin, S., & Chase, H. P. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.1512 · Cited by 4
Cryer, P. E. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00034-1 · Cited by 5
Cloning, expression and purification of feline proinsulin
Hoenig, M. E., Caffall, Z. F., McGraw, R. A., & Ferguson, D. C. (2005) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2005.05.005 · Cited by 4
Huang, C., Rosolowsky, E. T., Nour, M. A., Butalia, S., Ho, J., Mayengbam, S., Wang, W., Pyke, S., Virtanen, H., & Reimer, R. A. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-102486 · Cited by 3
Effect of bariatric surgery on glycemic profiles in multiethnic obese nondiabetic Asians
Teh, J. L., Leong, W. Q., Tan, Y. Z., So, J. B. Y., Kim, G., & Shabbir, A. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.11.017 · Cited by 3
Dynamic circadian fluctuations of glycemia in patients with type 2 diabetes mellitus
Vásquez-Muñoz, M., Arce-Álvarez, A., Álvarez, C., Ramirez-Campillo, R., Crespo, F., Arias, D., Salazar-Ardiles, C., Izquierdo, M., & Andrade, D. (2022) · Biological Research · doi:10.1186/s40659-022-00406-1 · Cited by 3
Pedersen, I. B., Kjølby, M., Hjelholt, A. J., Madsen, M., Christensen, A.-M. R., Adolfsen, D., Hjelle, J. S., Kremke, B., Støvring, H., Jessen, N., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-084808 · Cited by 3
Jacobsen, L. M., Atkinson, M. A., Campbell‐Thompson, M., & Schatz, D. (2016) · Diabetes Care · doi:10.2337/dc16-0737 · Cited by 3
Next-gen therapeutics to spare and expand beta-cell mass
Bolla, A. M., Usuelli, V., Nasr, M. B., Frigerio, S., Loretelli, C., D’Addio, F., & Fiorina, P. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.09.001 · Cited by 3
Prevention of Type 1 Diabetes Mellitus
Pozzilli, P., & Guglielmi, C. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_49 · Cited by 3
Therapies aimed at preservation or restoration of beta cell function in type 1 diabetes.
Keymeulen, B. (2008) · PubMed · Cited by 3
Update on Treatment of Type 1 Diabetes in Childhood
Ludvigsson, J. (2013) · Current Pediatrics Reports · doi:10.1007/s40124-013-0012-x · Cited by 3
Tang, K., Yan, J., Shen, Y., Li, B., Chen, Y., Liu, D., Ma, D., Li, J., Liang, H., & Weng, J. (2013) · Journal of Diabetes · doi:10.1111/1753-0407.12084 · Cited by 3
Blood glucose awareness training helps return insulin-treated aviators to the cockpit.
Grossman, A., Barenboim, E., Azaria, B., Goldstein, L., & Cohen, O. (2005) · PubMed · Cited by 3
Danielson, K., Monson, R., & LeCaire, T. J. (2016) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0035-1569374 · Cited by 3
Taylor, G., Shaw, A., Scragg, J. H., Smith, K., Campbell, M. D., McDonald, T. J., Shaw, J., Ross, M., & West, D. J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.797438 · Cited by 3
The Epidemiology of Diabetic Retinopathy
Klein, R., & Klein, R. (2006) · Elsevier eBooks · doi:10.1016/b978-0-323-02598-0.50091-4 · Cited by 3
Dantas, J. R., de Almeida, M. H., Barone, B., Campos, F., Kupfer, R., Milech, A., Zajdenverg, L., Rodacki, M., & de Oliveira, J. E. P. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000100010 · Cited by 3
Zhang, X., You, W., Li, Y., Li, F., Hao, S., Sun, Y., Li, N., Lin, L., Dou, J., Su, X., et al. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15026 · Cited by 2
Nallapu, C., Dayal, D., Sachdeva, N. K., Kumar, M., & Attri, S. V. (2025) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2025-0206 · Cited by 2
The potential role of hydrogen sulfide-autophagy axis in diseases
Chu, T., Wang, Y.-W., Cao, L., Wang, X., Fan, Y.-Q., Chen, Y., Zhang, Y., Si, W.-R., Jiang, Q., & Wu, D. (2025) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-025-01128-0 · Cited by 2
Detectable C-Peptide and Diabetic Ketoacidosis Risk in Type 1 Diabetes
Abuabat, M. I., Budhram, D., Bapat, P., BAKHSH, A., Zhang, Y., Cheema, W., Verhoeff, N. J., Mumford, D., Orszag, A., Fralick, M., et al. (2026) · Diabetes Care · doi:10.2337/dc26-0220 · Cited by 2
Changes in C-Peptide Values in Children with Type 1 Diabetes – a Three-Year Study
Novac, C. N., Mihai, D. A., Boboc, A. A., Plătică, C., Nemuc, A., & Radulian, G. (2023) · MAEDICA – a Journal of Clinical Medicine · doi:10.26574/maedica.2023.18.2.182 · Cited by 2
Boughton, C. K., Allen, J. M., Ware, J., Wilinska, M. E., Hartnell, S., Thankamony, A., Randell, T. L., Ghatak, A., Besser, R. E. J., Elleri, D., et al. (2024) · Efficacy and Mechanism Evaluation · doi:10.3310/ktfr5698 · Cited by 2
Song, D. K., Hong, Y. S., Sung, Y., & Lee, H. (2024) · PLoS ONE · doi:10.1371/journal.pone.0312439 · Cited by 2
Application of Fetal Stem Cells in Diabetes: Iran’s Experience
Tootee, A., Nasli‐Esfahani, E., & Larijani, B. A. (2015) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 2
Carbonated beverage consumption is associated with lower C-peptide in adolescents
Shengkai, Y., Chen, H., Ren, X., Wen, J., Du, Y., Li, X., Zhang, R., Li, Y., Zhang, B., Du, D., et al. (2019) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2018-0286 · Cited by 2
Metabolic impact of residual C-peptide secretion in type 1 diabetes mellitus
Lopes, V., Sousa, M. E., Lopes, S. G. D. C., & Lages, A. D. S. (2024) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-4292-2023-0503 · Cited by 3
An overview of non-insulin adjunctive therapies for Type 1 diabetes
Ballav, C., & Gough, S. C. L. (2014) · Diabetes Management · doi:10.2217/dmt.14.38 · Cited by 2
Peptídeo C e mortalidade cardiovascular: revisão sistemática e metanálise
Andrade, R. L. M., Quinte, G. C., & Horta, B. L. (2018) · Revista Panamericana de Salud Pública · doi:10.26633/rpsp.2019.23 · Cited by 2
Yuan, J., Zhang, J., Cutfield, W. S., Dong, G., Jiang, Y., Wu, W., Huang, K., Chen, X., Zheng, Y., Liu, B., et al. (2021) · World Journal of Pediatrics · doi:10.1007/s12519-020-00382-0 · Cited by 2
McCarthy, O. M., Pitt, J. P., Eckstein, M. L., Moser, O., Bain, S. C., & Bracken, R. M. (2021) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002613 · Cited by 2
Laser application in tooth bleaching: an update review.
Mohammadi, Z., Palazzi, F., & Giardino, L. (2011) · PubMed · Cited by 2
Cimbek, E. A., Öztürk, M. A., & Karagüzel, G. (2022) · Turkish Journal of Diabetes and Obesity · doi:10.25048/tudod.1059061 · Cited by 2
Stammzellbasierte Inselzelltransplantation: Meilenstein zur Therapie des Typ-1-Diabetes
Ludwig, B. (2023) · Deutsches Ärzteblatt · doi:10.3238/persdia.2023.11.03.03 · Cited by 2
Ekhlaspour, L., Buckingham, B. A., Bauza, C. E., Clements, M. A., Forlenza, G. P., Neyman, A., Norlander, L., Schamberger, M. S., Sherr, J. L., Bailey, R. J., et al. (2024) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2024.100352 · Cited by 2
Rewers, M. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0141 · Cited by 2
Gluten: do only celiac patients benefit from its removal from the diet?
Franckilin, L. R. D. S., dos Santos, A. C. P. M., Freitas, F. E. D. A., Vieira, I. G., Jorge, C. E. D. F., Neri, D. G., de Abreu, M. V. C., Fonseca, J. K., Loffi, R. G., & Foureaux, G. (2022) · Food Reviews International · doi:10.1080/87559129.2021.2024566 · Cited by 3
Immunotherapy of Type-1 Diabetes: Immunoprevention and Immunoreversal
Waldron-Lynch, F., & Herold, K. C. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-478-4_18 · Cited by 2
Epidemiology of diabetes in a well defined population in Sweden: the Skaraborg Diabetes Registry
Berger, B. (2006) · Lund University Publications (Lund University) · Cited by 2
Adiponectin and immune tolerance in type 1 diabetes
Pang, T. (2011) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 2
Skyler, J. S. (2010) · Wiley eBooks · doi:10.1002/9780470682807.ch4 · Cited by 2
Preserving Pancreatic Beta Cell Function in Recent-Onset Type 1 Diabetes
Couper, J. (2023) · JAMA · doi:10.1001/jama.2023.2140 · Cited by 2
A Case Report of LADA in the Primary Care Setting
Barton-Maxwell, V. (2023) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2023.104539 · Cited by 1
Lahn, V., Tittel, S. R., Ohlenschläger, U., Kamrath, C., Hammersen, J. E., Gellai, R., Mönkemöller, K., Dost, A., Bartelt, H., & Holl, R. W. (2025) · Pediatric Diabetes · doi:10.1155/pedi/9903467 · Cited by 1
Anvari, E., Lundkvist, P., Singh, K. N., & Espes, D. (2025) · Acta Diabetologica · doi:10.1007/s00592-025-02537-9 · Cited by 1
Odyjewska, E., Kupińska, M., Jamiołkowska‐Sztabkowska, M., Bossowski, A. T., & Głowińska‐Olszewska, B. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1602777 · Cited by 1
Wang, Z., Deng, M., Guo, L., & Pan, Q. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i9.109414 · Cited by 1
Yefou, M. D., Ymelong, M. N. M., Etoga, M. C. E., Agoons, B. B., Katte, J.-C. N., Feutseu, C., Boli, A. O., & Sobngwi, E. (2026) · Cureus · doi:10.7759/cureus.104502 · Cited by 1
Tol, M. C., de Vos, W., Alwayn, I. P. J., Mieog, J. S. D., van Hooft, J. E., Inderson, A., Niesters, M., Hellinga, M. D., Nijhoff, M. F., van Erkel, A. R., et al. (2026) · Diabetologia · doi:10.1007/s00125-026-06772-9 · Cited by 1
Carlsson, S., Midthjell, K., & Grill, V. (2013) · Norsk Epidemiologi · doi:10.5324/nje.v23i1.1601 · Cited by 1
Nursing interventions in autologous stem cell transplantation for autoimmune diseases
Nilsen, L., dos Santos, B. N., Leopoldo, V. C., dos Reis, P. E. D., Oliveira, M. C., Clark, A. M., & Silveira, R. C. D. C. P. (2020) · Journal of Advanced Nursing · doi:10.1111/jan.14559 · Cited by 1
Silvestri, F., Infante, M., Fabbri, A., Ferrara, C., Ferraguti, G., Costantino, F., Ferrari, E., Bonci, E., Turchetti, A., Tiberti, C., et al. (2022) · Pediatric Endocrinology Diabetes and Metabolism · doi:10.5114/pedm.2022.118317 · Cited by 1
Garcia, A. C.-G., Kaur, K., Talib, R., Salemi, P., Fishbein, J. S., & Nwosu, B. U. (2025) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2025-0332 · Cited by 1
In light of recent clinical trial results, what lies next for Type 1 diabetes vaccine research?
Ludvigsson, J. (2012) · Expert Review of Vaccines · doi:10.1586/erv.11.194 · Cited by 1
Initiating insulin in type 2 diabetes mellitus: the earlier the better.
Cohen, O. (2004) · PubMed · Cited by 1
Kühtreiber, W. M., Davis, M., & Faustman, D. L. (2017) · InTech eBooks · doi:10.5772/65598 · Cited by 1
Garavelli, S., Prattichizzo, F., Ceriello, A., Galgani, M., & de Candia, P. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0053 · Cited by 1
Zhang, L., Guo, K., Xu, Y., Bai, J., Ma, Y., Fu, L., Liu, J., Hu, K., Li, X., Jiang, H., et al. (2022) · PubMed Central · doi:10.11817/j.issn.1672-7347.2022.210524 · Cited by 1
Metadata
- Authors
- Steffes, M. W., Sibley, S., Jackson, M., & Thomas, W.
- Affiliations
- University of Minnesota (US)
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2003-03-01
- Volume
- 26
- Issue
- 3
- Pages
- 832-836
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W1988519907
- Cited by
- 695
- References
- 25
- Citations by year
- 2026: 20 · 2025: 26 · 2024: 30 · 2023: 34 · 2022: 39 · 2021: 49 · 2020: 38 · 2019: 29 · 2018: 31 · 2017: 32 · 2016: 30 · 2015: 44 · 2014: 32 · 2013: 53 · 2012: 37
- FWCI
- 8.55
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Center for Research Resources (M01RR000400, M01-RR00400)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- type 1 diabetes, residual beta-cell function, C-peptide, diabetic retinopathy, diabetic nephropathy, albuminuria, severe hypoglycemia, intensive insulin therapy, diabetes complications, Diabetes Control and Complications Trial
- MeSH terms
- Adult, Blood Glucose, C-Peptide, Diabetes Mellitus, Type 1, Diabetic Nephropathies, Diabetic Retinopathy, Female, Glycated Hemoglobin, Humans, Hypoglycemia, Islets of Langerhans, Male, Retrospective Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
